Please Wait...

sRANKL (Total) // Total Soluble Receptor Activator of Nuclear Factor Kappa B Ligand

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Formerly known as TNF-related activation-induced cytokine (TRANCE), the receptor activator of Nf-κB ligand (RANKL) was initially identified as an osteoprotegerin ligand (Lacey et al., 2012). RANKL is a member of the TNF superfamily and exists as a transmembrane protein and in a soluble form (after proteolytic cleavage or alternative mRNA splicing). There are three known spliced variants in human and the smallest of these three variants lacks the transmembrane and the intracellular domain and is directly secreted. The two other variants can be shed and released by proteases (MMP-3, MMP-7, MMP-14, ADAM10, ADAM17 and ADAM19) (Schramek et al., 2010). RANKL, RANK, and osteoprotegerin are a key molecular regulation system for bone remodeling. RANKL is an essential factor for the maturation and survival of osteoclasts. With the Wnt/β-catenin, they are the two major signaling pathway in regulation of bone mass (Boyce and Xing, 2007).

Bioclinica Lab employs two assays to measure RANKL. The assays are designed for the measurement of free RANKL (using recombinant osteoprotegerin for capture and polyclonal antibodies for detection) and total RANKL (sandwich immunoassay) in human serum.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Integration of #eTMF and #CTMS eliminates redundancies, improves workflows & enables greater study control. Join th… https://t.co/1917MtlAsA
Bioclinica (5 days ago)
Thinking of building a study in-house? Here are the 5 things you should think about before starting a DIY study bui… https://t.co/xzZWQOm49S
Bioclinica (2 weeks ago)
Integration of #eTMF and #CTMS eliminates redundancies, improves workflows & enables greater study control. Join th… https://t.co/Hoqf18zcPF
Bioclinica (2 weeks ago)
Your #IRT should not be the limiting factor during study start-up. The core features of Bioclinica's IRT agile plat… https://t.co/kitdsWvJ2S
Bioclinica (2 weeks ago)
Presenting Bioclinica CTMS: a rapid startup #CTMS that takes 2 weeks to implement, rather than months. Bioclinica C… https://t.co/tclYFoJx2z
Bioclinica (3 weeks ago)
Improve doc & study mgmt. across all studies by integrating #eTMF & #CTMS. In this webinar, Bioclinica &… https://t.co/UyoQyJVDah
Bioclinica (3 weeks ago)